Halozyme Therapeutic (NQ: HALO )
51.68
-0.72
(-1.37%)
Streaming Delayed Price
Updated: 11:57 AM EDT, Jun 26, 2024
Add to My Watchlist
Headline News about Halozyme Therapeutic![]() ![]() ![]()
Janssen's Subcutaneous Darzalex Combo Wins FDA Approval For Pretreated Multiple Myeloma
December 02, 2021
Via Benzinga
Exposures
Product Safety
![]()
The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight
August 08, 2021
Via Benzinga
Exposures
Product Safety
![]() ![]() ![]()
Halozyme Therapeutics, inc (HALO) Q3 2021 Earnings Call Transcript
November 03, 2021
Via The Motley Fool
Topics
Earnings
Exposures
Financial
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() Via Benzinga
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]()
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|